Skip to content
The Nexus
DossierENTITY

Immune System Biotech Odyssey

Coverage of Immune System Biotech Odyssey in the Nexus archive.

Earliest in view: May 4 · 10:45 UTCMost recent: May 4 · 10:45 UTC
Co-mentioned in this coverage
USplace1Bloombergorganization1Waldo Swiegersperson1
Recent coverage
  • BUSINESSMay 4 · 10:45 UTCBLOOMBERG
    Immune System Biotech Odyssey Seeks $238.3 Million in US IPO

    Immune System Biotech Odyssey is seeking $238.3 million in a US initial public offering. The company is involved in biotechnology related to the immune system. This IPO is a significant step for the company's growth and development.